Unlock every chart with Pro. First week for $1 »

Serious Bitcoin analysis needs serious data.

Try Pro for just $1 your first week.

Claim offer
Back to Treasuries

Conduit Pharmaceuticals Inc.

#131 in public CDT public

CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets.

Bitcoin Holdings

Total Bitcoin ₿ 17.909 BTC
% of 21M Supply 0.0%
Current Value $1,155,037
Cost Basis $2,002,506
ROI -42.32%
% of Company 52.4%
mNAV 1.91x
BTC/Share ₿ 0.00000046 BTC
Market Cap $2,205,794
Enterprise Value $2,205,794
Latest Purchase Oct 17, 2025
Avg. cost / BTC $111,816

Conduit Pharmaceuticals Inc. Stock Priced in BTC

0.000044 BTC

Conduit Pharmaceuticals Inc. Bitcoin Holdings Over Time

₿ 17.909 BTC

Bitcoin Acquisitions History

Loading acquisitions…

Company financial detail

Loading company details…

Frequently Asked Questions

Common questions about Conduit Pharmaceuticals Inc.'s Bitcoin holdings

How much Bitcoin does Conduit Pharmaceuticals Inc. hold?

Conduit Pharmaceuticals Inc. currently holds 17.909 BTC, which represents 0.0% of the total Bitcoin supply (21 million). This makes them the 131st largest public Bitcoin holder.

What is the current value of Conduit Pharmaceuticals Inc.'s Bitcoin holdings?

As of today, Conduit Pharmaceuticals Inc.'s Bitcoin holdings are worth approximately $1,155,037. This represents 52.4% of the company's total market value.

What is Conduit Pharmaceuticals Inc.'s average cost basis for Bitcoin?

Conduit Pharmaceuticals Inc.'s average cost basis for their Bitcoin purchases is $2,002,506 per Bitcoin. Their current return on investment (ROI) is -42.32%.

When did Conduit Pharmaceuticals Inc. last buy Bitcoin?

Conduit Pharmaceuticals Inc.'s most recent Bitcoin purchase was Oct 17, 2025. View purchase details

What type of company is Conduit Pharmaceuticals Inc.?

Conduit Pharmaceuticals Inc. is a public company in the Healthcare sector and Biotechnology industry with approximately 4 employees .

What is Conduit Pharmaceuticals Inc.'s market capitalization?

Conduit Pharmaceuticals Inc. has a market capitalization of approximately $2,205,794 and annual revenue of $0 .

What is Conduit Pharmaceuticals Inc.'s mNAV?

Conduit Pharmaceuticals Inc.'s mNAV (Market-to-Net Asset Value) is 1.91x, comparing the company's market value to its Bitcoin holdings value. An mNAV of 1.0 means market value equals Bitcoin stash, while >1.0 indicates a premium for the company's Bitcoin strategy.

What is Conduit Pharmaceuticals Inc.'s market cap and enterprise value?

Conduit Pharmaceuticals Inc. has a market capitalization of $2,205,794 and an enterprise value of $2,205,794. Enterprise value represents the total company value including debt and cash, providing a more complete valuation picture than market cap alone.

Other public Companies

Similar companies with Bitcoin treasury holdings

Strategy, Inc

MSTR

Holdings 840,447 BTC
Value $54,204,410,749
ROI -6.04%

Twenty One Capital, Inc.

XXI

Holdings 43,514 BTC
Value $2,806,424,116
ROI -39.82%

Metaplanet Inc.

MTPLF

Holdings 43,000 BTC
Value $2,773,273,820
ROI -35.98%

Marathon Digital Holdings Inc

MARA

Holdings 35,303 BTC
Value $2,276,857,806
ROI -15.99%

Cantor Equity Partners I, Inc.

CEPO

Holdings 30,021 BTC
Value $1,936,196,590
ROI -46.26%
Chat

Loading…

Opening chat…